- call +1-201-465-4211
- email sales@mrinsights.biz
The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.
Scope of the Report:
This report studies the Diabetic Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Diabetic Therapeutic market by product type and applications/end industries.
The report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this market in the coming years. With the recent years witnessing an increase in number of people diagnosed with type 1 diabetes, there has been considerable increase in the adoption of insulin delivery systems. Focusing on skipping the need to schedule appointments and reduce expenses for clinical visits, increases the adoption of insulin delivery systems, where individuals use insulin injections at home under the guidance of a physician. This led to the introduction of insulin pens, pumps, and jet injectors, which, in turn, will drive the growth of the diabetic therapeutics market.
Characterized by the presence of numerous small and large-scale vendors, the diabetes treatment market appears to be highly competitive. The market is dominated by the major players such as AstraZeneca, Novo Nordisk, Merck, Eli Lilly, and Sanofi who are competing against each other to lead the market. The market also consists of a number of local manufacturers in various countries and will also witness the entry of several new players, which will further intensify the level of competition in the market. To increase their revenue shares and improve market position, vendors are focusing on strategic alliances which will help them in marketing and manufacturing drugs.
In terms of geographical regions, the Americas will be the major revenue contributor to the diabetic therapeutics market throughout the predicted period. The increasing prevalence of diabetes in countries such as the US, which provides opportunities for vendors to develop new, more efficient, and safer drugs will be the major factor driving market growth in this segment.
The global Diabetic Therapeutic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Diabetic Therapeutic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
Amgen
Amicus Therapeutics
Arbutus Biopharma
Arena Pharmaceuticals
Astellas Pharma
Atheronova
Biodel
BioMarin
Bionaturis
Biosidus
Biospherics
Boehringer Ingelheim
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type 1
Type 2
Gestational
Market Segment by Applications, can be divided into
Insulin therapies
Non-insulin therapies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Diabetic Therapeutic Market Overview
1.1 Product Overview and Scope of Diabetic Therapeutic
1.2 Classification of Diabetic Therapeutic by Types
1.2.1 Global Diabetic Therapeutic Revenue Comparison by Types (2017-2023)
1.2.2 Global Diabetic Therapeutic Revenue Market Share by Types in 2017
1.2.3 Type 1
1.2.4 Type 2
1.2.5 Gestational
1.3 Global Diabetic Therapeutic Market by Application
1.3.1 Global Diabetic Therapeutic Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Insulin therapies
1.3.3 Non-insulin therapies
1.4 Global Diabetic Therapeutic Market by Regions
1.4.1 Global Diabetic Therapeutic Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Diabetic Therapeutic Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Diabetic Therapeutic Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetic Therapeutic Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Diabetic Therapeutic Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetic Therapeutic Status and Prospect (2013-2023)
1.5 Global Market Size of Diabetic Therapeutic (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Diabetic Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Diabetic Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Diabetic Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novo Nordisk
2.4.1 Business Overview
2.4.2 Diabetic Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novo Nordisk Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Diabetic Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.6 AbbVie
2.6.1 Business Overview
2.6.2 Diabetic Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AbbVie Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.7 Actelion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Diabetic Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Actelion Pharmaceuticals Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.8 Adocia
2.8.1 Business Overview
2.8.2 Diabetic Therapeutic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Adocia Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aegerion Pharmaceuticals
2.9.1 Business Overview
2.9.2 Diabetic Therapeutic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aegerion Pharmaceuticals Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.10 Akros Pharma
2.10.1 Business Overview
2.10.2 Diabetic Therapeutic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Akros Pharma Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.11 Alnylam Pharmaceuticals
2.11.1 Business Overview
2.11.2 Diabetic Therapeutic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Alnylam Pharmaceuticals Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amarin
2.12.1 Business Overview
2.12.2 Diabetic Therapeutic Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Amarin Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.13 Amgen
2.13.1 Business Overview
2.13.2 Diabetic Therapeutic Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Amgen Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.14 Amicus Therapeutics
2.14.1 Business Overview
2.14.2 Diabetic Therapeutic Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Amicus Therapeutics Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.15 Arbutus Biopharma
2.15.1 Business Overview
2.15.2 Diabetic Therapeutic Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Arbutus Biopharma Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.16 Arena Pharmaceuticals
2.16.1 Business Overview
2.16.2 Diabetic Therapeutic Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Arena Pharmaceuticals Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.17 Astellas Pharma
2.17.1 Business Overview
2.17.2 Diabetic Therapeutic Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Astellas Pharma Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.18 Atheronova
2.18.1 Business Overview
2.18.2 Diabetic Therapeutic Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Atheronova Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.19 Biodel
2.19.1 Business Overview
2.19.2 Diabetic Therapeutic Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Biodel Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.20 BioMarin
2.20.1 Business Overview
2.20.2 Diabetic Therapeutic Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 BioMarin Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.21 Bionaturis
2.21.1 Business Overview
2.2.2 Diabetic Therapeutic Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Bionaturis Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.22 Biosidus
2.22.1 Business Overview
2.22.2 Diabetic Therapeutic Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Biosidus Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.23 Biospherics
2.23.1 Business Overview
2.23.2 Diabetic Therapeutic Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Biospherics Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.24 Boehringer Ingelheim
2.24.1 Business Overview
2.24.2 Diabetic Therapeutic Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Boehringer Ingelheim Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.25 Bristol-Myers Squibb
2.25.1 Business Overview
2.25.2 Diabetic Therapeutic Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Bristol-Myers Squibb Diabetic Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diabetic Therapeutic Market Competition, by Players
3.1 Global Diabetic Therapeutic Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetic Therapeutic Players Market Share
3.2.2 Top 10 Diabetic Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global Diabetic Therapeutic Market Size by Regions
4.1 Global Diabetic Therapeutic Revenue and Market Share by Regions
4.2 North America Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
4.3 Europe Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
4.5 South America Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
5 North America Diabetic Therapeutic Revenue by Countries
5.1 North America Diabetic Therapeutic Revenue by Countries (2013-2018)
5.2 USA Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
5.3 Canada Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
5.4 Mexico Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
6 Europe Diabetic Therapeutic Revenue by Countries
6.1 Europe Diabetic Therapeutic Revenue by Countries (2013-2018)
6.2 Germany Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
6.3 UK Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
6.4 France Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
6.5 Russia Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
6.6 Italy Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Diabetic Therapeutic Revenue by Countries
7.1 Asia-Pacific Diabetic Therapeutic Revenue by Countries (2013-2018)
7.2 China Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
7.3 Japan Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
7.4 Korea Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
7.5 India Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
8 South America Diabetic Therapeutic Revenue by Countries
8.1 South America Diabetic Therapeutic Revenue by Countries (2013-2018)
8.2 Brazil Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
8.3 Argentina Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
8.4 Colombia Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Diabetic Therapeutic by Countries
9.1 Middle East and Africa Diabetic Therapeutic Revenue by Countries (2013-2018)
9.2 Saudi Arabia Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
9.3 UAE Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
9.4 Egypt Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
9.5 Nigeria Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
9.6 South Africa Diabetic Therapeutic Revenue and Growth Rate (2013-2018)
10 Global Diabetic Therapeutic Market Segment by Type
10.1 Global Diabetic Therapeutic Revenue and Market Share by Type (2013-2018)
10.2 Global Diabetic Therapeutic Market Forecast by Type (2018-2023)
10.3 Type 1 Revenue Growth Rate (2013-2023)
10.4 Type 2 Revenue Growth Rate (2013-2023)
10.5 Gestational Revenue Growth Rate (2013-2023)
11 Global Diabetic Therapeutic Market Segment by Application
11.1 Global Diabetic Therapeutic Revenue Market Share by Application (2013-2018)
11.2 Diabetic Therapeutic Market Forecast by Application (2018-2023)
11.3 Insulin therapies Revenue Growth (2013-2018)
11.4 Non-insulin therapies Revenue Growth (2013-2018)
12 Global Diabetic Therapeutic Market Size Forecast (2018-2023)
12.1 Global Diabetic Therapeutic Market Size Forecast (2018-2023)
12.2 Global Diabetic Therapeutic Market Forecast by Regions (2018-2023)
12.3 North America Diabetic Therapeutic Revenue Market Forecast (2018-2023)
12.4 Europe Diabetic Therapeutic Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Diabetic Therapeutic Revenue Market Forecast (2018-2023)
12.6 South America Diabetic Therapeutic Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Diabetic Therapeutic Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Diabetic Therapeutic Picture
Table Product Specifications of Diabetic Therapeutic
Table Global Diabetic Therapeutic and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
